Results 331 to 340 of about 11,905,956 (387)

Retrotransposon Expression Is Upregulated in Adulthood and Suppressed during Regeneration of the Limb in the Axolotl (Ambystoma mexicanum)

open access: yesAdvanced Biology, EarlyView.
The axolotl's remarkable regenerative abilities decline with age, the causes may include the numerous repetitive elements within its genome. This study uncovers how Ty3 retrotransposons and coexpression networks involving muscle and immune pathways respond to aging and regeneration, suggesting that transposons respond to physiological shifts and may ...
Samuel Ruiz‐Pérez   +8 more
wiley   +1 more source

The microenvironment of ulcerated acral melanoma is characterised by an inflammatory milieu and an enhanced humoral immune response

open access: yes
Vázquez-Cruz ME   +26 more
europepmc   +1 more source

Current and Future Cornea Chip Models for Advancing Ophthalmic Research and Therapeutics

open access: yesAdvanced Biology, EarlyView.
This review analyzes cornea chip technology as an innovative solution to corneal blindness and tissue scarcity. The examination encompasses recent developments in biomaterial design and fabrication methods replicating corneal architecture, highlighting applications in drug screening and disease modeling while addressing key challenges in mimicking ...
Minju Kim   +3 more
wiley   +1 more source

A model for predicting bacteremia species based on host immune response. [PDF]

open access: yesFront Cell Infect Microbiol
Simons P   +6 more
europepmc   +1 more source

Corrigendum to “Proteins from SARS-CoV-2 reduce T cell proliferation: A mirror image of sepsis” [Heliyon Volume 6, Issue 12, December 2020, Article e05635]

open access: yesHeliyon
José Avendaño-Ortiz   +12 more
doaj  

Immune Response Against SARS-CoV-2. [PDF]

open access: yesVaccines (Basel)
Stufano A, Schino V, Lucchese G.
europepmc   +1 more source

Reduced immune response to SARS-CoV-2 infection in the elderly after 6 months. [PDF]

open access: yesFront Immunol
Luo Q   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy